Considering how the media references the treatment as Regeneron and a polyclonal, they just don’t want to see this work as effectively as it has been reported. Big optics on the clinical outcomes here, especially after adding remdesivir. Of course, since he “took hydroxychloroquin”, why didn’t that protect him??
Considering how the media references the treatment as Regeneron and a polyclonal, they just don’t want to see this work as effectively as it has been reported. Big optics on the clinical outcomes here, especially after adding remdesivir. Of course, since he “took hydroxychloroquin”, why didn’t that protect him??
I’ll anyone able to offer up a realistic answer to why the stock is dropping? It hit $650 well before the Covid treatment has any data. Maybe the brain trust at the top don’t have the magic touch.
